Overview

A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year

Status:
Completed
Trial end date:
2017-05-03
Target enrollment:
Participant gender:
Summary
A study in which two groups of patients will be analysed; patients converted from Prograf to Advagraf within the first 3 months after transplantation and patients converted from Prograf to Advagraf between 3 months and 1 year after transplantation.
Details
Lead Sponsor:
Astellas Pharma S.A.S.
Treatments:
Tacrolimus